Ask AI
ProCE Banner Activity

Oncology Team Training: Improving Clinical Outcomes in Patients Receiving Immune Checkpoint Inhibitors for Solid Tumors

Slideset

Download these slides from a recent educational program to determine optimal immunotherapy strategies and improve clinical outcomes for your patients with solid tumors (lung, colorectal, or melanoma) receiving immune checkpoint inhibitors.

Released: March 13, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Merck Sharp & Dohme LLC.

Merck Sharp & Dohme, LLC

Target Audience

This activity is intended for physicians, nurse practitioners, nurse navigators, physician associates, nurses, and pharmacists who care for patients with solid tumors.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Determine optimal immunotherapy strategies based on clinical experience, expert perspectives, and consensus guidelines for patients with solid tumors

  • Identify, assess, and manage immune-related adverse events in patients with solid tumors receiving ICI monotherapy or ICI-based combination regimens

  • Select optimal ICI-based treatment strategies for patients in special populations, such as squamous histology, liver disease, and CNS metastases

  • Actively engage patients receiving ICI-based therapy in their treatment plan